Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bon Natural Life (BON) Long-Term Investments (2020 - 2025)

Bon Natural Life (BON) has disclosed Long-Term Investments for 5 consecutive years, with $27.8 million as the latest value for Q3 2024.

  • On a quarterly basis, Long-Term Investments rose 18.28% to $27.8 million in Q3 2024 year-over-year; TTM through Sep 2024 was $27.8 million, a 18.28% increase, with the full-year FY2024 number at $27.8 million, up 18.28% from a year prior.
  • Long-Term Investments was $27.8 million for Q3 2024 at Bon Natural Life, up from $23.5 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $27.8 million in Q3 2024 to a low of $10.5 million in Q3 2020.
  • A 5-year average of $19.1 million and a median of $19.1 million in 2022 define the central range for Long-Term Investments.
  • Peak YoY movement for Long-Term Investments: soared 40.35% in 2021, then grew 18.28% in 2024.
  • Bon Natural Life's Long-Term Investments stood at $10.5 million in 2020, then surged by 40.35% to $14.8 million in 2021, then increased by 29.52% to $19.1 million in 2022, then increased by 22.98% to $23.5 million in 2023, then grew by 18.28% to $27.8 million in 2024.
  • Per Business Quant, the three most recent readings for BON's Long-Term Investments are $27.8 million (Q3 2024), $23.5 million (Q3 2023), and $19.1 million (Q3 2022).